Talal T. Baki, MD

Talal T. Baki , MD;

William C. Little , MD;

Vascular Complications in Women after Catheterization and Percutaneous Coronary Intervention 1998‚Äì2005

David C. Sane , MD;

Mark A. Grabarczyk , MD;

Jason E. Goodin , BA;

Sidney Statonk , MD;

Several clinical trials have demonstrated that platelet glycoprotein (GP) IIb/IIIa receptor inhibition reduces the ischemic complications of percutaneous coronary interventions (PCI).1–4 Comparative data between agents, however, are very...

Several clinical trials have...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Renato M. Santos , MD;

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;

Propensity Score Analysis of Vascular Complications after
Diagnostic Cardiac Catheterization and Percutaneous Coronary Interven

Women have been shown historically to have a greater risk of complications than men following invasive procedures.1–5 The increased incidence of complications in women appears to occur independently of other factors known to influence the...

Women have been shown...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;

Automated Contrast Injection in Contemporary Practice during Cardiac Catheterization and PCI: Effects on Contrast-Induced Nephr

Renato M. Santos , MD;

Cardiac catheterization and PCI are usually performed by percutaneous access using the femoral artery. Following completion of the procedure, hemostasis is traditionally performed by manual compression, followed by 6 hours of bed rest....

Cardiac catheterization and PCI...

08/01/2008

Journal of Invasive Cardiology

Original Contribution

08/01/2008

Jason Call , MD;

Renato M. Santos , MD;

Talal T. Baki , MD;

Frederic R. Kahl , MD;

William C. Little , MD;